Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Feeling abnormal, Gait disturbance, Hypoaesthesia, Limb discomfort
Clinical narrative: He had an MRI done from his cervical spine down and his Neurosurgeon told him that he had something related to a virus /feeling weird the first week of May and it got worst after the second dose.; Numbness on his legs, entirely/ numbness on intimate parts/numbness on gluteus/ numbness on anus; He could not walk; feeling weird; it's been 6 weeks since he cannot go to work.; Parasthesia; Feeling where my feet are; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (He had an MRI done from his cervical spine down and his Neurosurgeon told him that he had something related to a virus /feeling weird the first week of May and it got worst after the second dose.), HYPOAESTHESIA (numbness on his legs, entirely/ numbness on intimate parts/numbness on gluteus/ numbness on anus), GAIT DISTURBANCE (he could not walk), FEELING ABNORMAL (feeling weird) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (it's been 6 weeks since he cannot go to work.) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  The patient's past medical history included Benign positional vertigo. Concurrent medical conditions included Hypertension, Alcohol abuse, Back pain, Chronic cough, Dizziness, Dyspnea exertional, Herpes simplex, Hypertriglyceridemia, Metabolic syndrome, Dyslipidemia, Prediabetes, Rectal pain and Vertigo. Concomitant products included LISINOPRIL for Hypertension, ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, BACLOFEN, BIMATOPROST (LUMIGAN) and MECLIZINE HCL for an unknown indication.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (He had an MRI done from his cervical spine down and his Neurosurgeon told him that he had something related to a virus /feeling weird the first week of May and it got worst after the second dose.), HYPOAESTHESIA (numbness on his legs, entirely/ numbness on intimate parts/numbness on gluteus/ numbness on anus), GAIT DISTURBANCE (he could not walk), FEELING ABNORMAL (feeling weird), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (it's been 6 weeks since he cannot go to work.), PARAESTHESIA (Parasthesia) and LIMB DISCOMFORT (Feeling where my feet are). The patient was treated with GABAPENTIN at a dose of 300 milligram three times a day. At the time of the report, CONDITION AGGRAVATED (He had an MRI done from his cervical spine down and his Neurosurgeon told him that he had something related to a virus /feeling weird the first week of May and it got worst after the second dose.), HYPOAESTHESIA (numbness on his legs, entirely/ numbness on intimate parts/numbness on gluteus/ numbness on anus), GAIT DISTURBANCE (he could not walk), FEELING ABNORMAL (feeling weird), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (it's been 6 weeks since he cannot go to work.), PARAESTHESIA (Parasthesia) and LIMB DISCOMFORT (Feeling where my feet are) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient  had an MRI done from his cervical spine down and his Neurosurgeon told him that he had something . Concomitant medications included high blood pressure medication, cholesterol medication.   This case was linked to MOD-2021-255588 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: follow up does not contain new information On 02-Aug-2021: Significant follow up added reported information. added current conditions, added products and the events.